Key facts
| Price (PPV) | 18.40 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | nifuroxazide |
| Class | Antidiarrheals and intestinal anti-infectives |
| ATC code | A07AX03 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boîte de 16 |
| Nature | Médicament |
| Hospital price | 11.50 MAD |
| Data collected on | 9/8/2026 |
Indications
Diarrhée aiguë présumée d'origine bactérienne en l'absence de suspicion de phénomènes invasifs (altération de l'état général, fièvre, signes toxi-infectieux...). Le traitement ne dispense pas de mesures diététiques et d'une réhydratation si elle est nécessaire. L'importance de la réhydratation par soluté de réhydratation orale ou par voie intraveineuse doit être adaptée en fonction de l'intensité de la diarrhée, de l'âge et des particularités du patient (maladies associées,etc...).
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 4 other products contain the same active substance as Apazide 200 mg (Nifuroxazide), at the same strength and in the same dosage form. For the same pack size (Boîte de 16), the cheapest is Nifox 200 mg (GENPHARMA) at 12.10 MAD, i.e. 34 % less than Apazide 200 mg (18.40 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Nifox 200 mg | GENPHARMA | Boîte de 16 | 12.10 MAD | 0.76 / unit | −34 % |
| Roxid 200 mg | GALENICA | Boîte de 16 | 17.10 MAD | 1.07 / unit | −7 % |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Enteral 200 mg | LAPROPHAN | Boîte de 12 | 14.80 MAD | 1.23 / unit |
| Roxid 200 mg | GALENICA | Boîte de 28 | 28.80 MAD | 1.03 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Apazide 200 mg
Apazide 200 mg belongs to the antidiarrheals and intestinal anti-infectives therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Apazide 200 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Apazide 200 mg
Answers to common questions from Moroccan patients about this drug.